Literature DB >> 29074538

TGFβ Promotes Genomic Instability after Loss of RUNX3.

Vaidehi Krishnan1, Yu Lin Chong2, Tuan Zea Tan2, Madhura Kulkarni2,3, Muhammad Bakhait Bin Rahmat2, Lavina Sierra Tay2, Haresh Sankar2, Doorgesh S Jokhun4,5, Amudha Ganesan2, Linda Shyue Huey Chuang2, Dominic C Voon2, G V Shivashankar4,5, Jean-Paul Thiery6,7, Yoshiaki Ito1.   

Abstract

Studies of genomic instability have historically focused on intrinsic mechanisms rather than extrinsic mechanisms based in the tumor microenvironment (TME). TGFβ is the most abundantly secreted cytokine in the TME, where it imparts various aggressive characteristics including invasive migration, drug resistance, and epithelial-to-mesenchymal transition (EMT). Here we show that TGFβ also promotes genomic instability in the form of DNA double strand breaks (DSB) in cancer cells that lack the tumor suppressor gene RUNX3 Loss of RUNX3 resulted in transcriptional downregulation of the redox regulator heme oxygenase-1 (HO-1 or HMOX1). Consequently, elevated oxidative DNA damage disrupted genomic integrity and triggered cellular senescence, which was accompanied by tumor-promoting inflammatory cytokine expression and acquisition of the senescence-associated secretory phenotype (SASP). Recapitulating the above findings, tumors harboring a TGFβ gene expression signature and RUNX3 loss exhibited higher levels of genomic instability. In summary, RUNX3 creates an effective barrier against further TGFβ-dependent tumor progression by preventing genomic instability. These data suggest a novel cooperation between cancer cell-extrinsic TGFβ signaling and cancer cell-intrinsic RUNX3 inactivation as aggravating factors for genomic instability.Significance: RUNX3 inactivation in cancer removes an antioxidant barrier against DNA double strand breaks induced by TGFβ expressed in the tumor microenvironment. Cancer Res; 78(1); 88-102. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29074538     DOI: 10.1158/0008-5472.CAN-17-1178

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  CHD4 mutations promote endometrial cancer stemness by activating TGF-beta signaling.

Authors:  Yang Li; Qingxin Liu; Daniel J McGrail; Hui Dai; Kaiyi Li; Shiaw-Yih Lin
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

2.  RUNX3 levels in human hematopoietic progenitors are regulated by aging and dictate erythroid-myeloid balance.

Authors:  Peter Balogh; Emmalee R Adelman; John V Pluvinage; Brian J Capaldo; Katie C Freeman; Sandeep Singh; Kamaleldin E Elagib; Yukio Nakamura; Ryo Kurita; Goro Sashida; Eli R Zunder; Hui Li; Alejandro A Gru; Elizabeth A Price; Stanley L Schrier; Irving L Weissman; Maria E Figueroa; Wendy W Pang; Adam N Goldfarb
Journal:  Haematologica       Date:  2019-06-06       Impact factor: 9.941

3.  Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants.

Authors:  Peter T Campbell; Yi Lin; Stephanie A Bien; Jane C Figueiredo; Tabitha A Harrison; Mark A Guinter; Sonja I Berndt; Hermann Brenner; Andrew T Chan; Jenny Chang-Claude; Steven J Gallinger; Susan M Gapstur; Graham G Giles; Edward Giovannucci; Stephen B Gruber; Marc Gunter; Michael Hoffmeister; Eric J Jacobs; Mark A Jenkins; Loic Le Marchand; Li Li; John R McLaughlin; Neil Murphy; Roger L Milne; Polly A Newcomb; Christina Newton; Shuji Ogino; John D Potter; Gad Rennert; Hedy S Rennert; Jennifer Robinson; Lori C Sakoda; Martha L Slattery; Yiqing Song; Emily White; Michael O Woods; Graham Casey; Li Hsu; Ulrike Peters
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506

4.  Identification of Tumor Mutation Burden, Microsatellite Instability, and Somatic Copy Number Alteration Derived Nine Gene Signatures to Predict Clinical Outcomes in STAD.

Authors:  Chuanzhi Chen; Yi Chen; Xin Jin; Yongfeng Ding; Junjie Jiang; Haohao Wang; Yan Yang; Wu Lin; Xiangliu Chen; Yingying Huang; Lisong Teng
Journal:  Front Mol Biosci       Date:  2022-04-11

Review 5.  Emerging role of RUNX3 in the regulation of tumor microenvironment.

Authors:  Sarala Manandhar; You Mie Lee
Journal:  BMB Rep       Date:  2018-04       Impact factor: 4.778

6.  BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma.

Authors:  Yi-Peng Yu; Li-Cheng Cai; Xing-Yuan Wang; Si-Yu Cheng; Da-Ming Zhang; Wen-Gang Jian; Teng-da Wang; Jian-Kun Yang; Kong-Bin Yang; Cheng Zhang
Journal:  Cancer Sci       Date:  2020-04-07       Impact factor: 6.716

7.  Inhibition of PIM1 attenuates the stem cell-like traits of breast cancer cells by promoting RUNX3 nuclear retention.

Authors:  Hui Liu; Cheng Chen; Dongshen Ma; Yubing Li; Qianqian Yin; Qing Li; Chenxi Xiang
Journal:  J Cell Mol Med       Date:  2020-04-19       Impact factor: 5.310

Review 8.  The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways.

Authors:  Michael J Birrer; Keiichi Fujiwara; Ana Oaknin; Leslie Randall; Laureen S Ojalvo; Christian Valencia; Isabelle Ray-Coquard
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

Review 9.  RUNX family: Oncogenes or tumor suppressors (Review).

Authors:  Beatriz Andrea Otálora-Otálora; Berta Henríquez; Liliana López-Kleine; Adriana Rojas
Journal:  Oncol Rep       Date:  2019-05-06       Impact factor: 3.906

10.  EB virus-induced ATR activation accelerates nasopharyngeal carcinoma growth via M2-type macrophages polarization.

Authors:  Bo Zhang; Tianyu Miao; Xin Shen; Lirong Bao; Cheng Zhang; Caixia Yan; Wei Wei; Jiao Chen; Liying Xiao; Chongkui Sun; Jintao Du; Yan Li
Journal:  Cell Death Dis       Date:  2020-09-11       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.